Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2020-06-01
2023-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Anti-hypertensive Therapy and Exercise Treatment to Improve Vascular Health in Patients With Hypertension.
NCT06823570
Examining Different Modes of Exercise for Acute Reduction in Blood Pressure
NCT06628635
Effect of Exercise on Selected Anthropometric,Biochemical and Physiological Variables Among Hypertensive Patients
NCT03029767
Improving Blood Pressure and Cardiovascular Risk With Resistance Exercise in African Americans
NCT03016351
Aerobic Exercise in Postexercise Cardiovascular Responses in Resistant Hypertension: a Cross-over Trial
NCT02249507
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
isometric handgrip exercise
4x2 minutes of isometric handgrip exercise
Exercise
aerobic exercise for 30 minutes at 40-60% HRres
control
seated control session
No interventions assigned to this group
Aerobic exercise
aerobic exercise at 40-60% HRres
Exercise
aerobic exercise for 30 minutes at 40-60% HRres
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise
aerobic exercise for 30 minutes at 40-60% HRres
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with high- normal BP (SBP: 130 - 139 mmHg or and DBP: 85 - 89 mmHg) or stage I hypertension (SBP: 140 - 159 mmHg or DBP: 90 - 99 mmHg) according to the ESC/ESH guidelines \[15\]
* Asian or African descent
* Do not meet the level of physical activity recommended by the WHO based on self-report \[15\]
* Non-medicated patients or patients using a maximum of 2 antihypertensive drugs
Exclusion Criteria
* History of ischemic stroke, autonomic neuropathy, cardiovascular, renal, or pulmonary disease by self-report
* Diabetes type I or II
* Pregnancy
* The presence of exercise induced signs of myocardial ischemia or complex ventricular arrhythmia during CPET
* Patients using three or more antihypertensive drugs or patients with resistant hypertension
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Véronique Cornelissen
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Anton De Kom University
Paramaribo, , Suriname
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
183/2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.